Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
- PMID: 24281251
- PMCID: PMC4361356
- DOI: 10.1177/2047487313514895
Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
Abstract
Background: Hyperuricaemia, the biochemical precursor to gout, has been shown to be an independent risk factor for mortality from cardiovascular disease (CVD), although studies examining the clinical phenomenon of gout and risk of CVD mortality report conflicting results. This study aimed to produce a pooled estimate of risk of mortality from cardiovascular disease in patients with gout.
Design: Systematic review and meta-analysis.
Methods: Electronic bibliographic databases were searched from inception to November 2012, with results reviewed by two independent reviewers. Studies were included if they reported data on CVD mortality in adults with gout who were free of CVD at time of entry into the study. Pooled hazard ratios (HRs) for this association were calculated both unadjusted and adjusted for traditional vascular risk factors.
Results: Six papers, including 223,448 patients, were eligible for inclusion (all (CVD) mortality n = 4, coronary heart disease (CHD) mortality n = 3, and myocardial infarction mortality n = 3). Gout was associated with an excess risk of CVD mortality (unadjusted HR 1.51 (95% confidence interval, CI, 1.17-1.84)) and CHD mortality (unadjusted HR 1.59, 95% CI 1.25-1.94)). After adjusting for traditional vascular risk factors, the pooled HR for both CVD mortality (HR 1.29, 95% CI 1.14-1.44) and CHD mortality (HR 1.42, 95% CI 1.22-1.63) remained statistically significant, but none of the studies reported a significant association with myocardial infarction.
Conclusions: Gout increases the risk of mortality from CVD and CHD, but not myocardial infarction, independently of vascular risk factors.
Keywords: Cardiovascular disease; coronary heart disease; gout; mortality; myocardial infarction.
© The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Figures
Similar articles
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Health Technol Assess. 2013. PMID: 24074752 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
A systematic review and economic evaluation of statins for the prevention of coronary events.Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140. Health Technol Assess. 2007. PMID: 17408535
-
Patient education in the management of coronary heart disease.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3. Cochrane Database Syst Rev. 2017. PMID: 28658719 Free PMC article.
Cited by
-
Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis.Clin Rheumatol. 2018 Jul;37(7):1879-1884. doi: 10.1007/s10067-018-3980-y. Epub 2018 Jan 27. Clin Rheumatol. 2018. PMID: 29374353 Free PMC article.
-
The Singapore Experience With Uncontrolled Gout: Unmet Needs in the Management of Patients.Cureus. 2023 Mar 25;15(3):e36682. doi: 10.7759/cureus.36682. eCollection 2023 Mar. Cureus. 2023. PMID: 36987445 Free PMC article. Review.
-
Risk of vascular events in patients with polymyalgia rheumatica.CMAJ. 2014 Sep 16;186(13):E495-501. doi: 10.1503/cmaj.140266. Epub 2014 Jul 28. CMAJ. 2014. PMID: 25070989 Free PMC article.
-
Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies.PLoS One. 2015 Jul 31;10(7):e0134088. doi: 10.1371/journal.pone.0134088. eCollection 2015. PLoS One. 2015. PMID: 26230580 Free PMC article.
-
Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.Arthritis Rheumatol. 2019 Nov;71(11):1935-1942. doi: 10.1002/art.41008. Epub 2019 Sep 25. Arthritis Rheumatol. 2019. PMID: 31169353 Free PMC article.
References
-
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011; 63: 3136–3141. - PubMed
-
- Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690–1697. - PubMed
-
- Szabo SM, Levy AR, Rao SR, et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 2011; 63: 3294–3304. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical